Nuclear factor kappa B--molecular biomedicine: the next generation.

Biomed Pharmacother

Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.

Published: January 2005

Nuclear factor kappa B (NFkappaB) as a transcription factor plays an important integrating role in the intracellular regulation of immune response, inflammation and cell cycle regulation. Nouvelle insights into the structure and regulation of activation of NFkappaB have brought a detailed picture of the function of this transcription factor. In this review the findings of interactions of NFkappaB with its inhibitors, tumour necrosis factor alpha and glucocorticoids are presented. The results from the latest in vivo studies show the capability of specific NFkappaB inhibitors in the clinical use. This article summarizes the most important facts regarding NFkappaB participation in the pathogenesis of diseases and its potential as a target of pharmacological agents.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2003.12.015DOI Listing

Publication Analysis

Top Keywords

nuclear factor
8
factor kappa
8
transcription factor
8
nfkappab inhibitors
8
nfkappab
5
kappa b--molecular
4
b--molecular biomedicine
4
biomedicine generation
4
generation nuclear
4
factor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!